These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 25977930)
21. Predictive utility of a genetic risk score of common variants associated with type 2 diabetes in a black South African population. Chikowore T; van Zyl T; Feskens EJ; Conradie KR Diabetes Res Clin Pract; 2016 Dec; 122():1-8. PubMed ID: 27744072 [TBL] [Abstract][Full Text] [Related]
22. Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study. Palmer ND; Goodarzi MO; Langefeld CD; Ziegler J; Norris JM; Haffner SM; Bryer-Ash M; Bergman RN; Wagenknecht LE; Taylor KD; Rotter JI; Bowden DW Diabetes; 2008 Apr; 57(4):1093-100. PubMed ID: 18252897 [TBL] [Abstract][Full Text] [Related]
23. [Association study between PPARGC1A Thr394Thr/ Gly482Ser polymorphisms and type 2 diabetes]. Su Y; Peng SB; Li ZQ; Huang QY Yi Chuan; 2008 Mar; 30(3):304-8. PubMed ID: 18331997 [TBL] [Abstract][Full Text] [Related]
24. The Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) is associated with type 2 diabetes in Tunisian population. Jemaa Z; Kallel A; Sleimi C; Mahjoubi I; Feki M; Ftouhi B; Slimane H; Jemaa R; Kaabachi N Diabetes Metab Syndr; 2015; 9(4):316-9. PubMed ID: 25470625 [TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes. Ng MC; Shriner D; Chen BH; Li J; Chen WM; Guo X; Liu J; Bielinski SJ; Yanek LR; Nalls MA; Comeau ME; Rasmussen-Torvik LJ; Jensen RA; Evans DS; Sun YV; An P; Patel SR; Lu Y; Long J; Armstrong LL; Wagenknecht L; Yang L; Snively BM; Palmer ND; Mudgal P; Langefeld CD; Keene KL; Freedman BI; Mychaleckyj JC; Nayak U; Raffel LJ; Goodarzi MO; Chen YD; Taylor HA; Correa A; Sims M; Couper D; Pankow JS; Boerwinkle E; Adeyemo A; Doumatey A; Chen G; Mathias RA; Vaidya D; Singleton AB; Zonderman AB; Igo RP; Sedor JR; ; Kabagambe EK; Siscovick DS; McKnight B; Rice K; Liu Y; Hsueh WC; Zhao W; Bielak LF; Kraja A; Province MA; Bottinger EP; Gottesman O; Cai Q; Zheng W; Blot WJ; Lowe WL; Pacheco JA; Crawford DC; ; ; Grundberg E; ; Rich SS; Hayes MG; Shu XO; Loos RJ; Borecki IB; Peyser PA; Cummings SR; Psaty BM; Fornage M; Iyengar SK; Evans MK; Becker DM; Kao WH; Wilson JG; Rotter JI; Sale MM; Liu S; Rotimi CN; Bowden DW; PLoS Genet; 2014 Aug; 10(8):e1004517. PubMed ID: 25102180 [TBL] [Abstract][Full Text] [Related]
26. Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans. Bailey JNC; Palmer ND; Ng MCY; Bonomo JA; Hicks PJ; Hester JM; Langefeld CD; Freedman BI; Bowden DW Hum Genet; 2014 Jun; 133(6):769-779. PubMed ID: 24385048 [TBL] [Abstract][Full Text] [Related]
27. A genome-wide association study of serum uric acid in African Americans. Charles BA; Shriner D; Doumatey A; Chen G; Zhou J; Huang H; Herbert A; Gerry NP; Christman MF; Adeyemo A; Rotimi CN BMC Med Genomics; 2011 Feb; 4():17. PubMed ID: 21294900 [TBL] [Abstract][Full Text] [Related]
28. Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study. Kao WH; Coresh J; Shuldiner AR; Boerwinkle E; Bray MS; Brancati FL; Diabetes; 2003 Jun; 52(6):1568-72. PubMed ID: 12765972 [TBL] [Abstract][Full Text] [Related]
29. PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level. Zhu L; Huang Q; Xie Z; Kang M; Ding H; Chen B; Chen Y; Liu C; Wang Y; Tang W Oncotarget; 2017 Jun; 8(23):37308-37320. PubMed ID: 28418876 [TBL] [Abstract][Full Text] [Related]
30. Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African-American population enriched for nephropathy. Sale MM; Smith SG; Mychaleckyj JC; Keene KL; Langefeld CD; Leak TS; Hicks PJ; Bowden DW; Rich SS; Freedman BI Diabetes; 2007 Oct; 56(10):2638-42. PubMed ID: 17601994 [TBL] [Abstract][Full Text] [Related]
31. Lack of direct evidence for natural selection at the candidate thrifty gene locus, PPARGC1A. Cadzow M; Merriman TR; Boocock J; Dalbeth N; Stamp LK; Black MA; Visscher PM; Wilcox PL BMC Med Genet; 2016 Nov; 17(1):80. PubMed ID: 27846814 [TBL] [Abstract][Full Text] [Related]
32. Impact of KCNQ1, CDKN2A/2B, CDKAL1, HHEX, MTNR1B, SLC30A8, TCF7L2, and UBE2E2 on risk of developing type 2 diabetes in Thai population. Plengvidhya N; Chanprasert C; Chongjaroen N; Yenchitsomanus PT; Homsanit M; Tangjittipokin W BMC Med Genet; 2018 Jun; 19(1):93. PubMed ID: 29871606 [TBL] [Abstract][Full Text] [Related]
33. Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy. Keene KL; Mychaleckyj JC; Smith SG; Leak TS; Perlegas PS; Langefeld CD; Freedman BI; Rich SS; Bowden DW; Sale MM Diabetes; 2008 Apr; 57(4):1057-62. PubMed ID: 18184924 [TBL] [Abstract][Full Text] [Related]
34. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study. Lehtinen AB; Newton-Cheh C; Ziegler JT; Langefeld CD; Freedman BI; Daniel KR; Herrington DM; Bowden DW Diabetes; 2008 Apr; 57(4):1108-14. PubMed ID: 18235038 [TBL] [Abstract][Full Text] [Related]
35. Common genetic variants in peroxisome proliferator-activated receptor-γ (PPARG) and type 2 diabetes risk among Women's Health Initiative postmenopausal women. Chan KH; Niu T; Ma Y; You NC; Song Y; Sobel EM; Hsu YH; Balasubramanian R; Qiao Y; Tinker L; Liu S J Clin Endocrinol Metab; 2013 Mar; 98(3):E600-4. PubMed ID: 23386649 [TBL] [Abstract][Full Text] [Related]
36. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects. Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736 [TBL] [Abstract][Full Text] [Related]
38. Risk of type 2 diabetes and obesity is differentially associated with variation in FTO in whites and African-Americans in the ARIC study. Bressler J; Kao WH; Pankow JS; Boerwinkle E PLoS One; 2010 May; 5(5):e10521. PubMed ID: 20502638 [TBL] [Abstract][Full Text] [Related]
39. A Genetic Risk Score Improves the Prediction of Type 2 Diabetes Mellitus in Mexican Youths but Has Lower Predictive Utility Compared With Non-Genetic Factors. Miranda-Lora AL; Vilchis-Gil J; Juárez-Comboni DB; Cruz M; Klünder-Klünder M Front Endocrinol (Lausanne); 2021; 12():647864. PubMed ID: 33776940 [TBL] [Abstract][Full Text] [Related]
40. Use of net reclassification improvement (NRI) method confirms the utility of combined genetic risk score to predict type 2 diabetes. Tam CH; Ho JS; Wang Y; Lam VK; Lee HM; Jiang G; Lau ES; Kong AP; Fan X; Woo JL; Tsui SK; Ng MC; So WY; Chan JC; Ma RC PLoS One; 2013; 8(12):e83093. PubMed ID: 24376643 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]